Investigation the determinants of pharmaceutical expenditure share of GDP in Iran and selected OECD countries
Aim This study estimated the GDP share of pharmaceuticals in Iran based on the drivers of pharmaceutical expenditure and compared it with that of 31 members of the Organisation for Economic Cooperation and Development (OECD). Subject and methods The factors contributing to pharmaceutical expenditure...
Saved in:
Main Authors: | Azin Kadkhodamanesh (Author), Vida Varahrami (Author), Leila Zarei (Author), Farzad Peiravian (Author), Mohammad Hadidi (Author), Nazila Yousefi (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2021-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Catastrophic pharmaceutical expenditure in patients with type 2 diabetes in Iran
by: Leila Zarei, et al.
Published: (2022) -
Bootstrap ARDL on Health Expenditure, CO2 Emissions, and GDP Growth Relationship for 18 OECD Countries
by: Chien-Ming Wang, et al.
Published: (2019) -
Parental self-medication with antibiotics in Iran
by: Farahnaz Zeinali, et al.
Published: (2018) -
Public and decision-maker stated preferences for pharmaceutical subsidy decisions in Iran: an application of the discrete choice experiment
by: Gita Afsharmanesh, et al.
Published: (2021) -
An investigation into the pharmaceutical advertising in Iranian medical journals
by: Nazila Yousefi, et al.
Published: (2022)